In vivo study to evaluate the protective effects of amifostine on radiation-induced damage of testis tissue

Oncology

Volumn 69, Issue 1, 2005, Pages 44-51

  Andrieu, Meltem Nalca ^a   Kurtman, Cengiz ^a   Hicsonmez, Ayse ^a   Ozbilgin, Kemal ^b   Eser, Erhan ^b   Erdemli, Esra ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Amifostine; Radiation protection; Testis

Indexed keywords

AMIFOSTINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ELECTRON MICROSCOPY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; RAT; SPERMATOCYTE; SPERMATOGONIUM; SPERMATOZOON COUNT; TESTIS INJURY; TESTIS WEIGHT; TREATMENT OUTCOME; ULTRASTRUCTURE;

AMIFOSTINE; ANIMALS; IN SITU NICK-END LABELING; MALE; MICROSCOPY; MICROSCOPY, ELECTRON; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEMINIFEROUS EPITHELIUM; SPERM COUNT; TESTIS;

EID: 23944516250     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087475     Document Type: Article

References (47)

1. Links M, Lewis C: Chemoprotectants: A review of their clinical pharmacology and therapeutic efficacy. Drugs 1999;57:293-308.
2. Peters GJ, van der Vijgh WJF: Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): Preclinical aspects. Eur J Cancer 1995;31:1-7.
3. Castiglione F, Dalla Mola A, Porcile G: Protection of normal tissues from radiation and cytotoxic therapy: The development of amifostine. Tumori 1999;85:85-91.
4. Yuhas JM, Storer JB: Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst 1969;42:331-335.
5. Ito H, Meistrich ML, Barkley HT, et al: Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721. Int J Radiat Oncol Biol Phys 1986;12:211-219.
6. Pratt NE, Sodicoff M: Morphological effects of WR-2721 on the rat parotid acinar cell. Radiat Res 1978;75:327-335.
7. Sodicoff M, Conger AD, Trepper B, et al: Short-term radioprotective effects of WR-2721 on the rat parotid glands. Radiat Res 1978;75:317-326.
8. Pratt NE, Sodicoff M, Liss J, et al: Radioprotection of the rat gland by WR-2721: Morphology at 60 days post-irradiation. Int J Radiat Oncol Biol Phys 1980;6:431-435.
9. Menard TW, Izutsu KT, Ensign WY, et al: Radioprotection by WR-2721 of gamma-irradiated rat parotid gland: Effect on gland weight and secretion at 8-10 days postirradiation. Int J Radiat Oncol Biol Phys 1984;10:1555-1559.
10. Williams MV, Denekamp J: Modification of the radiation response of the mouse kidney by misonidazole and WR-2721. Int J Radiat Oncol Biol Phys 1983;9:1731-1736.
11. Travis EL, Fang MZ, Basic I: Protection of mouse bone marrow by WR-2721 after fractionated irradiation. Int J Radiat Oncol Biol Phys 1988;15:377-382.
12. Benova D: Antimutagenic properties of WR-2721 and of a radioprotective mixture, ATP-AET-serotonin, with regard to X-ray induced reciprocal translocations in mouse spermatogonia. Int J Radiat Oncol Biol Phys 1987;13:117-119.
13. Meistrich MI, Finch MV, Hunter N, et al: Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation. Int J Radiat Oncol Biol Phys 1984;10:2099-2107.
14. Stewart FA, Rojas A: Radioprotection of mouse skin by WR-2721 in single and fractionated treatments. Br J Radiol 1982;55:42-47.
15. Hunter NR, Guttenberger R, Milas L: Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721. Int J Radiat Oncol Biol Phys 1992;22:795-798.
16. Travis EL, Newman RA, Helbing SJ: WR-2721 modification of type II cell and endothelial cell function in mouse lung after single doses of radiation. Int J Radiat Oncol Biol Phys 1987;13:1355-1359.
17. Meistrich MI, Finch MV, Hunter N, et al: Cytotoxic effects of WR-2721 on mouse testicular cells. Int J Radiat Oncol Biol Phys 1984;10:1551-1554.
18. Johnsen SG: Testicular biopsy score count - A method for registration of spermatogenesis in human testes: Normal values and results in 335 hypogonadal males. Hormones 1970;1:2-25.
19. Aslam I, Fishel S, Moore H, et al: Fertility preservation of boys undergoing anti-cancer therapy: A review of the existing situation and prospects for the future. Hum Reprod 2000;15:2154-2159.
20. Schrader M, Heicappel S, Muller M, et al: Impact of chemotherapy on male fertility. Onkologie 2001;24:326-330.
21. Kuczyk M, Machtens S, Bokemeyer C, et al: Sexual function and fertility after treatment of testicular cancer. Curr Opin Urol 2000;10:473-477.
22. Puscheck E, Philip PA, Jeyendran RS: Male fertility preservation and cancer treatment. Cancer Treat Rev 2004;30:173-180.
23. Littley MD, Shalet SM, Morgenstern GR, et al: Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 1991;78:265-274.
24. Shafford EA, Kingston JE, Malpas JS, et al: Testicular function following the treatment of Hodgkin's disease in childhood. Br J Cancer 1993;68:1199-1204.
25. Brougham MF, Kelnar CJ, Sharpe RM, et al: Male fertility following childhood cancer: Current concepts and future therapies. Asian J Androl 2003;5:325-337.
26. Ben Arush MW, Solt I, Lightman A, et al: Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma. Pediatr Hematol Oncol 2000;17:239-245.
27. Colpi GM, Contalbi GF, Nerva F, et al: Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol 2004;113(suppl 1):S2-S6.
28. Pacini F, Gasperi M, Fugazzola L, et al: Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J Nucl Med 1994;35:1418-1422.
29. Hyer S, Vini L, O'Connell M, et al: Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol (Oxf) 2002;56:755-758.
30. Wichers M, Benz E, Palmedo H, et al: Testicular function after radioiodine therapy for thyroid carcinoma. Eur J Nucl Med 2000;27:503-507.
31. Piroth MD, Hensley F, Wannenmacher M, et al: Male gonadal dose in adjuvant 3-d-pelvic irradiation after anterior resection of rectal cancer. Influence to fertility. Strahlenther Onkol 2003;179:754-759.
32. Huyghe E, Matsuda T, Daudin M, et al: Fertility after testicular cancer treatments: Results of a large multicenter study. Cancer 2004;100:732-737.
33. Malas S, Levin V, Sur RK, et al: Fertility in patients treated with radiotherapy following orchidectomy for testicular seminoma. Clin Oncol (R Coll Radiol) 1994;6:377-380.
34. Centola GM, Keller JW, Henzler M, et al: Effect of low dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 1994;15:608-612.
35. Shapiro E, Kinsella TJ, Makuch RW, et al: Effects of fractionated irradiation of endocrine aspects of testicular function. J Clin Oncol 1985;3:1232-1239.
36. Herrmann T: Radiation reactions in the gonads: Importance in patient counseling. Strahlenther Onkol 1997;173:493-501.
37. Naysmith TE, Blake DA, Harvey VJ, et al: Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod 1998;13:3250-3255.
38. Budgell GJ, Cowan RA, Hounsell AR: Prediction of scattered dose to the testes in abdominopelvic radiotherapy. Clin Oncol (R Coll Radiol) 2001;13:120-125.
39. Beckham WA: Secondary electron scatter in radiotherapy: Implications for treatment fields in proximity to the lens of the eye and the testes. Phys Med Biol 1993;38:1013-1018.
40. Jaimala, Bhartiya HC, Pareek BP: Effects of S-2(3-aminopropylamino) ethylphosphorothioic acid (WR-2721) on the sensitivity of mouse spermatogonia A to radiation. Acta Radiol Oncol 1984;23:65-68.
41. Jaimala: Inhibition of radiation induced changes in testicular RNA content by a thiophosphate. Radiobiol Radiother 1989;30:163-166.
42. Bhartiya HC, Jaimala: Inhibition of reduction in the testicular weight by WR-2721 in relation to the body weight after whole-body gamma irradiation (abstract). Strahlenther Onkol 1986;162:68-70.
43. Milas L, Hunter N, Reid BO: Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung and lung tumor nodules. Int J Radiat Oncol Biol Phys 1982;8:535-538.
44. Milas L, Hunter N, Reid BO, et al: Protective effects of S-2(3-aminopropylamino) ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res 1982;42:1888-1897.
45. Jahnukainen K, Hou M, Parvinen M, et al: Stage-specific inhibition of deoxyfibonucleic acid synthesis and induction of apoptosis by anthracyclines in cultured rat spermatogenic cells. Biol Reprod 2000;63:482-487.
46. Jahnukainen K, Jahnukainen T, Salmi TT, et al: Amifostine protects against early but not late toxic effects of doxorubicin in infant rats. Cancer Res 2001;61:6423-6427.
47. Rigatos SK, Stathopoulos GP, Dontas I, et al: Investigation of doxorubicin tissue toxicity: Does amifostine provide chemoprotection? An experimental study. Anticancer Res 2002;22:129-134.